Osify SM Tablet contains Ademetionine 400 mg, a naturally occurring compound involved in methylation processes and transsulfuration pathways essential for cellular function and liver health. It is primarily indicated for the treatment of liver disorders such as cholestasis, hepatic steatosis, and cirrhosis, as well as for the management of depressive disorders associated with hepatic dysfunction. Ademetionine acts by enhancing the synthesis of phospholipids, promoting hepatocyte membrane stability, and facilitating the regeneration of liver tissue. Additionally, it contributes to the modulation of neurotransmitter metabolism, which may improve mood and cognitive function. Osify SM Tablet is administered orally and is generally well-tolerated, with a favorable safety profile. Common adverse effects are rare but may include gastrointestinal discomfort or allergic reactions. The dosage and duration of therapy should be tailored according to the patient's clinical condition and response to treatment. Osify SM Tablet should be used under medical supervision, particularly in patients with severe hepatic impairment or concomitant medical conditions. It is contraindicated in individuals with hypersensitivity to Ademetionine or any excipients present in the formulation. This medication plays a significant role in supporting liver function and improving quality of life in patients with hepatic and mood disorders.